能谱CT及其特定值在非小细胞肺癌患者分期中的技术可行性与临床影响
前瞻性队列纳入113例确诊非小细胞肺癌患者,行单期增强能谱CT(80-140 kV快速管电压切换)测量恶性组织与淋巴结的碘含量、能谱斜率及放射密度增幅,肾上腺肿块用虚拟平扫评估。肺腺癌标准化碘含量19.37显著高于鳞癌12.03(p=0.035);转移性淋巴结碘含量2.08 mg/ml显著低于良性淋巴结2.58 mg/ml(p=0.023);虚拟平扫鉴别肾上腺腺瘤敏感度91%、特异度100%。
要点
- 肺腺癌标准化碘含量19.37高于鳞癌12.03(p=0.035),可能有助于区分非小细胞肺癌组织学亚型。
- 转移性淋巴结碘含量2.08 mg/ml低于良性淋巴结2.58 mg/ml(p=0.023),可能改善淋巴结转移识别。
- 虚拟平扫鉴别肾上腺腺瘤敏感度91%、特异度100%。
核心结论
- 能谱CT可能有助于区分非小细胞肺癌组织学亚型并改善淋巴结转移识别,虚拟平扫可鉴别肾上腺腺瘤与转移,碘图可显示肺栓塞相关灌注缺损。
研究设计与样本
- 前瞻性队列研究纳入113例确诊非小细胞肺癌患者,均行单期增强能谱CT(快速管电压切换技术,80-140 kV),测量恶性组织与淋巴结的碘含量、能谱斜率及放射密度增幅,肾上腺肿块用虚拟平扫系列评估。
关键影像表现/征象
- 52个未经治疗的原发非小细胞肺癌病灶可评估,肺腺癌标准化碘含量19.37高于鳞状细胞癌12.03(p=0.035)。
- 肺转移灶与良性肺结节间无显著差异。
- 共分析126枚淋巴结,组织学证实的转移性淋巴结碘含量2.08 mg/ml低于良性淋巴结2.58 mg/ml(p=0.023)。
- 34个肾上腺肿块中,虚拟平扫识别腺瘤敏感度91%、特异度100%。
- 2例患者碘图检出肺栓塞所致灌注缺损。
诊断标准与关键数值
- 肺腺癌标准化碘含量19.37 vs 鳞状细胞癌12.03(p=0.035)。
- 转移性淋巴结碘含量2.08 mg/ml vs 良性淋巴结2.58 mg/ml(p=0.023)。
- 虚拟平扫鉴别肾上腺腺瘤敏感度91%、特异度100%。
临床应用与阅片要点
- 能谱CT碘含量测量可能辅助区分非小细胞肺癌组织学亚型。
- 淋巴结碘含量测量可能改善转移性淋巴结识别。
- 虚拟平扫可用于鉴别肾上腺腺瘤与转移。
- 碘图可显示肺栓塞相关灌注缺损。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To investigate how spectral computed tomography (SCT) values impact the staging of non-small cell lung cancer (NSCLC) patients.
MATERIALS AND METHODS: One hundred and thirteen patients with confirmed NSCLC were included in a prospective cohort study. All patients underwent single-phase contrast-enhanced SCT (using the fast tube voltage switching technique, 80-140 kV). SCT values (iodine content [IC], spectral slope pitch, and radiodensity increase) of malignant tissue (primary and metastases) and lymph nodes (LNs) were measured. Adrenal masses were evaluated in a virtual non-contrast series (VNS). If pulmonary embolism was present, pulmonary perfusion was analysed as an additional finding.
RESULTS: Fifty-two untreated primary NSCLC lesions were evaluable. Lung adenocarcinoma had significantly higher normalised IC (NIC: 19.37) than squamous cell carcinoma (NIC: 12.03; p=0.035). Pulmonary metastases were not significantly different from benign lung nodules. A total of 126 LNs were analysed and histologically proven metastatic LNs (2.08 mg/ml) had significantly lower IC than benign LNs (2.58 mg/ml; p=0.023). Among 34 adrenal masses, VNS identified adenomas with high sensitivity (91%) and specificity (100%). In two patients, a perfusion defect due to pulmonary embolism was detected in the iodine images.
CONCLUSION: SCT may contribute to the differentiation of histological NSCLC subtypes and improve the identification of LN metastases. VNS differentiates adrenal adenoma from metastasis. In case of pulmonary embolism, iodine imaging can visualise associated pulmonary perfusion defects.
引用
- Fehrenbach U, Kahn J, Böning G, et al. Spectral CT and its specific values in the staging of patients with non-small cell lung cancer: technical possibilities and clinical impact. Clin Radiol. 2019. PMID: 30905380. doi:10.1016/j.crad.2019.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。